Journal of Surgery Concepts & Practice >

2020 , Vol. 25 >Issue 03: 202 - 206

DOI: https://doi.org/10.16139/j.1007-9610.2020.03.006

Experts forum

Status and development of endoscopic and laparoscopic treatment of gastric cancer

Expand

Received date: 2020-02-28

  Online published: 2020-05-25

Fold

Cite this article

ZHANG Shaopeng, LI Wei, SUO Jian . Status and development of endoscopic and laparoscopic treatment of gastric cancer[J]. Journal of Surgery Concepts & Practice, 2020 , 25(03) : 202 -206 . DOI: 10.16139/j.1007-9610.2020.03.006

References

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2] Kim W, Kim HH, Han SU, et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01)[J]. Ann Surg, 2016, 263(1):28-35.
[3] Kitano S, Shiraishi N, Uyama I, et al. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan[J]. Ann Surg, 2007, 245(1):68-72.
[4] Katai H, Mizusawa J, Katayama H, et al. Short-term surgical outcomes from a phase Ⅲ study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage ⅠA/ⅠB gastric cancer: Japan Clinical Oncology Group Study JCOG0912[J]. Gastric Cancer, 2017, 20(4):699-708.
[5] Shi Y, Xu X, Zhao Y, et al. Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer[J]. Surgery, 2018, 32(5):2427-2433.
[6] Hasuike N, Ono H, Boku N, et al. A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607)[J]. Gastric Cancer, 2018, 21(1):114-123.
[7] Yano T, Hasuike N, Ono H, et al. Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607)[J]. Gastric Cancer, 2020, 23(1):168-174.
[8] Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase Ⅲ multicenter, prospective, randomized Trial (KLASS Trial)[J]. Ann Surg, 2010, 251(3):417-420.
[9] Kim HH, Han SU, Kim MC, et al. Effect of laparoscopic distal gastrectomy vs open distal gastrectomy on long-term survival among patients with stage Ⅰ gastric cancer: the KLASS-01 randomized clinical trial[J]. JAMA Oncol, 2019, 5(4):506-513.
[10] Katai H, Sasako M, Fukuda H, et al. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage Ⅰ gastric cancer: a multicenter phase Ⅱ trial (JCOG 0703)[J]. Gastric Cancer, 2010, 13(4):238-244.
[11] Katai H, Mizusawa J, Katayama H, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage ⅠA or ⅠB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2020, 5(2):142-151.
[12] Katai H, Mizusawa J, Katayama H, et al. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage Ⅰ gastric cancer: Japan Clinical Oncology Group study JCOG1401[J]. Gastric Cancer, 2019, 22(5):999-1008.
[13] Hyung WJ, Yang HK, Han SU, et al. A feasibility study of laparoscopic total gastrectomy for clinical stage I gastric cancer: a prospective multi-center phase Ⅱ clinical trial, KLASS 03[J]. Gastric Cancer, 2019, 22(1):214-222.
[14] Yu J, Huang C, Sun Y, et al. Effect of laparoscopic vs. open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the 01 randomized clinical trial[J]. JAMA, 2019, 321(20):1983-1992.
[15] Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial[J]. J Clin Oncol, 2016, 34(12):1350-1357.
[16] Lee HJ, Hyung WJ, Yang HK, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer(KLASS-02-RCT)[J]. Ann Surg, 2019, 270(6):983-991.
[17] Inaki N, Etoh T, Ohyama T, et al. A multi-institutional, prospective, phase Ⅱ feasibility study of laparoscopy-assisted distal gastrectomy with D2 lymph node dissection for locally advanced gastric cancer (JLSSG0901)[J]. World J Surg, 2015, 39(11):2734-2741.
[18] Kurokawa Y, Sasako M, Sano T, et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia[J]. Br J Surg, 2015, 102(4):341-348.
[19] Lee J, Kim D, Kim W. Comparison of laparoscopy-assisted and totally laparoscopic Billroth-Ⅱ distal gastrectomy for gastric cancer[J]. J Korean Surg Soc, 2012, 82(3):135-142.
[20] Guerra F, Giuliani G, Formisano G, et al. Pancreatic complications after conventional laparoscopic radical gastrectomy versus robotic radical gastrectomy: systematic review and meta-analysis[J]. J Laparoendosc Adv Surg Tech A, 2018, 28(10):1207-1215.
[21] Ojima T, Nakamura M, Nakamori M, et al. Robotic versus laparoscopic gastrectomy with lymph node dissection for gastric cancer: study protocol for a randomized controlled trial[J]. Trials, 2018, 19(1):409.
Options
Outlines

/

〈 〉